The scientist’s investigation covers issues in Internal medicine, Transplantation, CD34, Stem cell and Myelodysplastic syndromes. Rainer Haas has included themes like Gastroenterology, Surgery and Oncology in his Internal medicine study. Rainer Haas works mostly in the field of Transplantation, limiting it down to topics relating to Salvage therapy and, in certain cases, Azacitidine, Complication and Corticosteroid.
His studies in CD34 integrate themes in fields like Progenitor cell, Haematopoiesis, Bone marrow and Cellular differentiation. The various areas that Rainer Haas examines in his Stem cell study include Cancer research and T-cell receptor. His study on International Prognostic Scoring System is often connected to European standard as part of broader study in Myelodysplastic syndromes.
His primary scientific interests are in Internal medicine, Myelodysplastic syndromes, Oncology, Transplantation and Immunology. The study incorporates disciplines such as Gastroenterology and Surgery in addition to Internal medicine. The Myelodysplastic syndromes study combines topics in areas such as Hematology, Pediatrics, Induction chemotherapy and Cohort.
Rainer Haas usually deals with Oncology and limits it to topics linked to Azacitidine and Decitabine. His Transplantation research is multidisciplinary, relying on both Leukemia, Salvage therapy, Stem cell and Multiple myeloma. His Immunology study combines topics in areas such as Progenitor cell, CD34 and Haematopoiesis.
Rainer Haas mostly deals with Internal medicine, Oncology, Myelodysplastic syndromes, Transplantation and Myeloid leukemia. His Internal medicine study frequently draws connections between adjacent fields such as Azacitidine. His study on Oncology also encompasses disciplines like
As part of the same scientific family, Rainer Haas usually focuses on Myelodysplastic syndromes, concentrating on Cohort and intersecting with Hazard ratio and Gastroenterology. While the research belongs to areas of Transplantation, Rainer Haas spends his time largely on the problem of Stem cell, intersecting his research to questions surrounding Granulocyte colony-stimulating factor. His research in Myeloid leukemia tackles topics such as Bone marrow which are related to areas like Haematopoiesis, Cancer research and Cell.
Internal medicine, Myelodysplastic syndromes, Oncology, Myeloid leukemia and Myeloid are his primary areas of study. A large part of his Internal medicine studies is devoted to Hematology. His Myelodysplastic syndromes study integrates concerns from other disciplines, such as Neuroblastoma RAS viral oncogene homolog and Median survival.
His Oncology research is multidisciplinary, incorporating perspectives in Univariate analysis, Hematopoietic stem cell transplantation, Transplantation and Minimal residual disease. His biological study spans a wide range of topics, including Stem cell and Allogeneic transplantation. His Myeloid research entails a greater understanding of Immunology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma.
Rainer Haas;Robert Möhle;Stefan Frühauf;Hartmut Goldschmidt.
Treatment of myelodysplastic syndromes with valproic acid alone or in combination with all-trans retinoic acid.
Andrea Kuendgen;Corinna Strupp;Manuel Aivado;Alf Bernhardt.
Successful autologous transplantation of blood stem cells mobilized with recombinant human granulocyte-macrophage colony-stimulating factor.
Haas R;Ho Ad;Bredthauer U;Cayeux S.
Experimental Hematology (1990)
Gene expression profiling identifies significant differences between the molecular phenotypes of bone marrow-derived and circulating human CD34+ hematopoietic stem cells.
Ulrich Steidl;Ralf Kronenwett;Ralf Kronenwett;Ulrich Peter Rohr;Ulrich Peter Rohr;Roland Fenk;Roland Fenk.
Azacitidine and donor lymphocyte infusions as first salvage therapy for relapse of AML or MDS after allogeneic stem cell transplantation
T Schroeder;A Czibere;U Platzbecker;G Bug.
Differential expression of L-selectin, VLA-4, and LFA-1 on CD34+ progenitor cells from bone marrow and peripheral blood during G-CSF-enhanced recovery.
Möhle R;Murea S;Kirsch M;Haas R.
Experimental Hematology (1995)
Successful autografting following myeloablative conditioning therapy with blood stem cells mobilized by chemotherapy plus rhG-CSF.
S Hohaus;H Goldschmidt;R Ehrhardt;R Haas.
Experimental Hematology (1993)
Thalidomide for the treatment of patients with myelodysplastic syndromes.
C Strupp;U Germing;M Aivado;E Misgeld.
Insufficient stromal support in MDS results from molecular and functional deficits of mesenchymal stromal cells
S. Geyh;S. Öz;R. P. Cadeddu;J. Fröbel.
Fast and reliable titration of recombinant adeno-associated virus type-2 using quantitative real-time PCR.
Ulrich Peter Rohr;Marc Andre Wulf;Susanne Stahn;Ulrich Steidl.
Journal of Virological Methods (2002)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: